- Home
- CLDI vs SMTK Comparison
CLDI vs SMTK Comparison
Compare CLDI & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- SMTK
- Stock Information
- Founded
- CLDI 2014
- SMTK 2009
- Country
- CLDI United States
- SMTK United Kingdom
- Employees
- CLDI N/A
- SMTK N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- SMTK
- Sector
- CLDI Health Care
- SMTK
- Exchange
- CLDI Nasdaq
- SMTK NYSE
- Market Cap
- CLDI 12.0M
- SMTK 13.3M
- IPO Year
- CLDI N/A
- SMTK N/A
- Fundamental
- Price
- CLDI $0.36
- SMTK $1.34
- Analyst Decision
- CLDI Strong Buy
- SMTK
- Analyst Count
- CLDI 1
- SMTK 0
- Target Price
- CLDI $10.00
- SMTK N/A
- AVG Volume (30 Days)
- CLDI 456.3K
- SMTK 98.3K
- Earning Date
- CLDI 05-14-2025
- SMTK 05-13-2025
- Dividend Yield
- CLDI N/A
- SMTK N/A
- EPS Growth
- CLDI N/A
- SMTK N/A
- EPS
- CLDI N/A
- SMTK N/A
- Revenue
- CLDI N/A
- SMTK $105,000.00
- Revenue This Year
- CLDI N/A
- SMTK N/A
- Revenue Next Year
- CLDI N/A
- SMTK N/A
- P/E Ratio
- CLDI N/A
- SMTK N/A
- Revenue Growth
- CLDI N/A
- SMTK 854.54
- 52 Week Low
- CLDI $0.34
- SMTK $1.00
- 52 Week High
- CLDI $3.89
- SMTK $8.16
- Technical
- Relative Strength Index (RSI)
- CLDI 34.85
- SMTK N/A
- Support Level
- CLDI $0.34
- SMTK N/A
- Resistance Level
- CLDI $0.39
- SMTK N/A
- Average True Range (ATR)
- CLDI 0.04
- SMTK 0.00
- MACD
- CLDI 0.00
- SMTK 0.00
- Stochastic Oscillator
- CLDI 15.45
- SMTK 0.00
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About SMTK SMARTKEM INC
SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in a number of applications including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.